Vaccitech sinks after IPO even though firm co-created AstraZeneca COVID-19 vaccine

U.K. biopharma Vaccitech (Nasdaq:VACC), co-inventor the Oxford University/AstraZeneca COVID-19 vaccine, saw its shares tank as much as nearly 25% Friday following the firm’s IPO.
Read More